MedlineFRA:L10 +5.16%14 Days Payable is 15.57 as of Mar. 2026, which is 1% above its 10-year median of 15.41. GuruFocus rates FRA:L10 with a GF Score™ of 14/100. The stock has 3 warning signs investors should review. Among 796 Medical Devices & Instruments companies, Medline ranks worse than 96.23% on this metric.
Medline's average Accounts Payable for the
three
months ended in Mar. 2026 was €813 Mil. Medline's Cost of Goods Sold for the
three
months ended in Mar. 2026 was €4,767 Mil.
Hence, Medline's Days Payable for the
three
months ended in Mar. 2026 was 15.57.
The historical rank and industry rank for Medline's Days Payable or its related term are showing as below:
FRA:L10'
s Days Payable Range Over the Past 10 Years
Min: 14.65 Med: 15.41 Max: 16.06
Current: 16.06
During the past 4 years, Medline's highest Days Payable was 16.06. The lowest was 14.65. And the median was 15.41.
FRA:L10's Days Payable is ranked worse than 96.23% of 796
companies
in the Medical Devices & Instruments industry
Industry Median: 68.14
vs FRA:L10: 16.06
Medline's Days Payable
declined
from Mar. 2025 (16.99) to Mar. 2026 (15.57).
It may suggest that Medlineaccelerated paying its suppliers.
Medline Days Payable Related Terms
Medline Days Payable Historical Data
* Premium members only.
The historical data trend for Medline's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Instruments & Supplies subindustry, Medline's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Medline Days Payable vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Medline's Days Payable distribution charts can be found below:
* The bar in red indicates where Medline's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Medline's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Medline (FRA:L10) has a Days Payable of 15.57 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Medline and its competitors. This is near median its historical median of 15.41. Over the past decade, Medline's Days Payable has ranged from 14.65 to 16.06. According to the industry distribution chart, Medline ranks #766 out of 796 companies in the Medical Devices & Instruments industry, placing it in the top 96.2%.
Is Medline's Days Payable too high?
Medline's current Days Payable of 15.57 is near median its 10-year median of 15.41. Over the past 10 years, this metric has ranged from a low of 14.65 to a high of 16.06. The Medical Devices & Instruments industry median Days Payable is 68.14. Medline's value of 15.57 is 77.1% below this industry median. Based on the distribution chart, Medline ranks #766 out of 796 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Medline has a GF Score™ of 14/100, reflecting its overall financial health beyond just this single metric.
How does Medline's Days Payable compare to RMD and WST?
According to the Medical Devices & Instruments industry distribution chart, Medline ranks #766 out of 796 companies for Days Payable. This places Medline in the lower half of its industry. The industry median Days Payable is 68.14. Medline's value of 15.57 is 77.1% below this benchmark. Historically, Medline's own Days Payable has ranged from 14.65 to 16.06 over the past decade. While the company's 10-year median is 15.41 vs. the industry median of 68.14, Medline has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Medical Devices & Instruments company?
The median Days Payable among Medical Devices & Instruments companies is 68.14, based on 796 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Medline's current Days Payable of 15.57 is 77.1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Medline and its competitors. For the Medical Devices & Instruments industry, the median Days Payable is 68.14 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Medline's current Days Payable is 15.57, which is near median its own 10-year median of 15.41. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medline stock overvalued right now?
Medline (FRA:L10) has a current Days Payable of 15.57. The current Days Payable is 15.57, which is near median its 10-year median of 15.41 and 77.1% below the Medical Devices & Instruments industry median of 68.14. Medline's overall GF Score™ is 14/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Medline (FRA:L10), the current Days Payable is 15.57 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Medline is the largest provider of medical-surgical products and supply chain solutions in the US. The company generates over 90% of its revenue domestically and serves some of the largest US health systems. Medline offers approximately 190,000 Medline-branded products across more than 250 product families—including front-line care, surgical solutions, and laboratory and diagnostics—as well as roughly 150,000 third-party products sourced from over 1,250 vendors. The company maintains prime vendor relationships with many customers, acting as the primary consolidated logistics partner for their medical-surgical needs. Medline has significant scale, supported by more than 30 manufacturing facilities and a fleet of over 2,000 owned delivery trucks. Medline went public in December 2025.
14GF Score
Get the complete analysis for FRA:L10
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:L10 has been successfully added to your 
